Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Recombinant Non-Glycosylated Proteins Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Biosimilars & Follow-on-Biologics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Biosimilars & Follow-on-Biologics is forecast to a readjusted size of US$ 60550 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential ... Read More
-
Global Retinal Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Retinal Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Retinal Biosimilars ... Read More
-
Global Pen Needles Market - 2024-2031
... period 2024-2031. The global pen needles market witnessed rise in demand as an increasing number of diabetes patients in which insulins are commonly used. Manufacturers introduce various innovative features such as ultra-thin needles, enhanced safety ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Monoclonal antibodies (mAbs) Biosimilars industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Monoclonal antibodies (mAbs) Biosimilars. The report ... Read More
-
Tumor Necrosis Factor Inhibitor Drugs Market Size, Trends, Analysis, and Outlook By Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Tumor Necrosis Factor Inhibitor Drugs market size is poised to register 1.73% growth ... Read More
-
Erythropoietin Drugs Market Size, Trends, Analysis, and Outlook By Type (Biologics, Biosimilars), By Product (Erythropoietin, Darbepoetin-alfa), By Application (Cancer, Renal Diseases, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... size is poised to register 4.85% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Erythropoietin Drugs market across By Type (Biologics, Biosimilars), ... Read More
-
Gastrointestinal Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Gastrointestinal Therapeutics market size is poised to register ... Read More
-
Opioid-Induced Constipation Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Opioid-Induced Constipation market size is poised to register ... Read More
-
Regulatory Affairs Market Size, Trends, Analysis, and Outlook By Services (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Others), By Category, Drugs, Biosimilars, Medical Devices), By Indication (Oncology, Neurology, Cardiology, Immunology, Others), By Product (Preclinical, Clinical studies, PMA), By Service (In-house, Outsourced), By Organisation Size, Small, Medium, Large), By End-user (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030
... Cardiology, Immunology, Others), By Product (Preclinical, Clinical studies, PMA), By Service (In-house, Outsourced), By Organisation Size, Small, Medium, Large), By End-user (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030 ... Read More
-
Biosimilar Monoclonal Antibodies Market Size, Trends, Analysis, and Outlook By Product (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab, Others), By Application (Oncology, Chronic & Autoimmune Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Biosimilar Monoclonal Antibodies market size is poised to register 20.64% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosimilar Monoclonal Antibodies market ... Read More
-
Pharmaceutical Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By ... Read More
-
Rare Diseases Treatment Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic Diseases, Endocrine Disorders, Others), By Route of Administration (Oral, Injectable, Others), By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Rare Diseases Treatment market size is poised to register 12.13% growth ... Read More
-
Global Erythropoietin (EPO) Drugs Market Growth 2024-2030
... market, the Erythropoietin (EPO) Drugs is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.4% during review period. The research report highlights the growth potential of the global ... Read More
-
Rheumatoid Arthritis Therapeutics Market Size, Trends, Analysis, and Outlook By Pharmaceuticals Molecule (NSAIDs, Analgesics, DMARDs, Glucocorticoids), By Biopharmaceuticals Molecule (Biologics, Biosimilars), By Sales Channel (Prescription, Over-the-Counter), by Region, Country, Segment, and Companies, 2024-2030
... Rheumatoid Arthritis Therapeutics market size is poised to register 4.95% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Rheumatoid Arthritis Therapeutics market ... Read More
-
Biopharmaceutical CMO and CRO Market Size, Trends, Analysis, and Outlook By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), by Region, Country, Segment, and Companies, 2024-2030
... and CRO market size is poised to register 6.11% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biopharmaceutical CMO and CRO market ... Read More
-
Pharmaceutical Regulatory Affairs Market Size, Trends, Analysis, and Outlook By Services (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Others), By Drugs (Innovator, Generics), By Biologics (Biotech, ATMP, Biosimilars), By Indication (Oncology, Neurology, Cardiology, Immunology, Others), By Product Stage (Preclinical, Clinical studies, PMA), By Service Provider (In-house, Outsourcing), By Organisation Size (Small, Medium, Large), by Region, Country, Segment, and Companies, 2024-2030
... By Indication (Oncology, Neurology, Cardiology, Immunology, Others), By Product Stage (Preclinical, Clinical studies, PMA), By Service Provider (In-house, Outsourcing), By Organisation Size (Small, Medium, Large), by Region, Country, Segment, and Companies, 2024-2030 The global Pharmaceutical ... Read More
-
Microbial Fermentation Technology Market Size, Trends, Analysis, and Outlook By Application (Antibiotics, Probiotics Supplements, Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes, Small Molecules, Others), By End-user (Bio-Pharmaceutical Companies, Contract Research Organizations (CROs), CMOs & CDMOs, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Microbial Fermentation Technology market size is poised to register 6.62% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
-
Biologics Contract Development and Manufacturing Organization Market Size, Trends, Analysis, and Outlook By Type (Mammalian, Microbial), By Product (Biologics, Biosimilars), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 8.33% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biologics Contract Development and Manufacturing Organization market ... Read More
-
Pharmaceutical Manufacturing Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)), By Drug Development (In-house, Outsource), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Route of Administration (Oral, Topical, Parenteral, Inhalations, Others), By Therapy Area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Others), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age group (Children & Adolescents, Adults, Geriatric), By Sales Channel (Retail, Non-retail), by Region, Country, Segment, and Companies, 2024-2030
... of Administration (Oral, Topical, Parenteral, Inhalations, Others), By Therapy Area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Others), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age group (Children & Adolescents, Adults, Geriatric), By Sales ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Related Biologics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilars
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
